BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29031898)

  • 1. Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression.
    Hu C; Lau AJ; Wang R; Chang TKH
    Eur J Pharmacol; 2017 Nov; 815():501-511. PubMed ID: 29031898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 20(R, S)-protopanaxadiol and 20(R, S)-protopanaxatriol for potential selective modulation of glucocorticoid receptor.
    Zhang T; Liang Y; Zuo P; Yan M; Jing S; Li T; Wang Y; Zhang J; Wei Z
    Food Chem Toxicol; 2019 Sep; 131():110642. PubMed ID: 31247261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-month toxicokinetic study of SHENMAI injection in rats.
    Yu J; Xin YF; Gu LQ; Gao HY; Xia LJ; You ZQ; Xie F; Ma ZF; Wang Z; Xuan YX
    J Ethnopharmacol; 2014 Jun; 154(2):391-9. PubMed ID: 24747029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of 13 Ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, Compound K, 20(
    Jin S; Jeon JH; Lee S; Kang WY; Seong SJ; Yoon YR; Choi MK; Song IS
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31323835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Dissociative Glucocorticoid Receptor Activity for Protopanaxadiol and Protopanaxatriol.
    Karra AG; Konstantinou M; Tzortziou M; Tsialtas I; Kalousi FD; Garagounis C; Hayes JM; Psarra AG
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice.
    Zhu H; He YS; Ma J; Zhou J; Kong M; Wu CY; Mao Q; Lin G; Li SL
    J Ethnopharmacol; 2021 Jan; 265():113271. PubMed ID: 32853742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of NF-κB inhibitors following Shenfu injection and bioactivity-integrated UPLC/Q-TOF-MS and screening for related anti-inflammatory targets in vitro and in silico.
    Li P; Lv B; Jiang X; Wang T; Ma X; Chang N; Wang X; Gao X
    J Ethnopharmacol; 2016 Dec; 194():658-667. PubMed ID: 27771457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herb-Drug Interaction of Red Ginseng Extract and Ginsenoside Rc with Valsartan in Rats.
    Jeon JH; Lee S; Lee W; Jin S; Kwon M; Shin CH; Choi MK; Song IS
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex components of Shengmai formula interact with organic cation transporter 2 (OCT2) in MDCK cells.
    Meng C; Zhong L; Lu T; Gu Q; Du X; Liu F; Xia C
    J Ethnopharmacol; 2023 May; 308():116278. PubMed ID: 36813246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
    Xu R; Peng Y; Wang M; Fan L; Li X
    J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of new special ginsenosidase hydrolyzing multi-glycisides of protopanaxadiol ginsenosides, ginsenosidase type I.
    Yu H; Zhang C; Lu M; Sun F; Fu Y; Jin F
    Chem Pharm Bull (Tokyo); 2007 Feb; 55(2):231-5. PubMed ID: 17268094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor.
    Niu CS; Yeh CH; Yeh MF; Cheng JT
    Horm Metab Res; 2009 Apr; 41(4):271-6. PubMed ID: 19048455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ginsenosides following repeated oral administration of red ginseng extract significantly differ between species of experimental animals.
    Jeon JH; Lee J; Choi MK; Song IS
    Arch Pharm Res; 2020 Dec; 43(12):1335-1346. PubMed ID: 33225388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach.
    Zarneshan SN; Fakhri S; Khan H
    Pharmacol Res; 2022 Mar; 177():106099. PubMed ID: 35092819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells.
    Lee YN; Lee HY; Chung HY; Kim SI; Lee SK; Park BC; Kim KW
    Eur J Cancer; 1996 Jul; 32A(8):1420-8. PubMed ID: 8869109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of glucocorticoid receptor in the induction of differentiation by ginsenosides in F9 teratocarcinoma cells.
    Lee YN; Lee HY; Lee YM; Chung HY; Kim SI; Lee SK; Park BC; Kim KW
    J Steroid Biochem Mol Biol; 1998 Oct; 67(2):105-11. PubMed ID: 9877210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Korean Ginseng Berry Fermented by Mycotoxin Non-producing Aspergillus niger and Aspergillus oryzae: Ginsenoside Analyses and Anti-proliferative Activities.
    Li Z; Ahn HJ; Kim NY; Lee YN; Ji GE
    Biol Pharm Bull; 2016; 39(9):1461-7. PubMed ID: 27582326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation.
    Ray DW; Suen CS; Brass A; Soden J; White A
    Mol Endocrinol; 1999 Nov; 13(11):1855-63. PubMed ID: 10551779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms.
    Fan W; Huang Y; Zheng H; Li S; Li Z; Yuan L; Cheng X; He C; Sun J
    Biomed Pharmacother; 2020 Dec; 132():110915. PubMed ID: 33254433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.